| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |